The role of serum nesfatin-1 in a rat model of acute pancreatitis
Advances in Clinical and Experimental Medicine · 2022
DOI: 10.17219/acem/156141 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Clinical and Experimental Medicine, 2022. Verfasst von Ayse Gul Ferlengez und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Reanimation, University of Health Sciences Istanbul Training and Research Hospital, Türkiye. Hauptthemen laut MEDLINE: Pancreatitis. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
BACKGROUND: Acute pancreatitis (AP) is a disease that can still be fatal despite rapid advances in medicine. The relationship between serum nesfatin-1 levels and AP is still to be fully resolved. OBJECTIVES: To investigate the utility of serum nesfatin-1 levels in the diagnosis of AP. MATERIAL AND METHODS: Twenty-four male Sprague Dawley rats were divided into control, mild pancreatitis and severe pancreatitis groups (n = 8/group). Acute pancreatitis was induced by cerulein injection and the control group received saline injections. Then, the serum nesfatin-1, amylase, lipase, aspartate aminotransferase (AST), and alanine aminotransferase (ALT) levels were determined. A pathologist blinded to the study scored the severity of pancreatitis. RESULTS: There was a considerable decrease in serum nesfatin-1 levels in parallel to the severity of pancreatitis, though there was no statistically significant relationship observed between pancreatitis and nesfatin-1. In addition, there was no significant difference in AST or ALT levels among the groups. However, a strong positive correlation between amylase and lipase levels was observed (p < 0.05). The severe pancreatitis group (group 3) had a higher lipase level and pathology score than mild pancreatitis group (group 2), and this difference was statistically significant. CONCLUSIONS: Serum nesfatin-1 may be used as a diagnostic and severity marker in pancreatitis in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology and Reanimation, University of Health Sciences Istanbul Training and Research Hospital, Türkiye.
- Department of General Surgery, University of Health Sciences Istanbul Training and Research Hospital, Türkiye.
- Department of General Surgery, Esenler Maternity and Children's Hospital, Istanbul, Türkiye.
- Department of General Surgery, University of Health Sciences Haseki Training and Research Hospital, Istanbul, Türkiye.
- Department of Pathology, Corlu State Hospital, Tekirdag, Türkiye.
Zitieren
APA
Ferlengez, A. G., Tatar, C., Degerli, M. S., Koyuncu, A., Ahlatci, F. A., Nayci, A. E., Ari, A., & Idiz, U. O. (2022). The role of serum nesfatin-1 in a rat model of acute pancreatitis. Advances in Clinical and Experimental Medicine. https://doi.org/10.17219/acem/156141
Vancouver
Ferlengez AG, Tatar C, Degerli MS, Koyuncu A, Ahlatci FA, Nayci AE, et al. The role of serum nesfatin-1 in a rat model of acute pancreatitis. Advances in Clinical and Experimental Medicine. 2022. doi:10.17219/acem/156141
BibTeX
@article{Ferlengez2022,
author = {Ferlengez, Ayse Gul and Tatar, Cihad and Degerli, Mahmut Said and Koyuncu, Adil and Ahlatci, Fatih Alper and Nayci, Ali Emre and Ari, Aziz and Idiz, Ufuk Oguz},
title = {The role of serum nesfatin-1 in a rat model of acute pancreatitis},
journal = {Advances in Clinical and Experimental Medicine},
year = {2022},
doi = {10.17219/acem/156141}
}
EUVIMED